Insider · CIK 0001532219

Quinn Anthony G.

CIK 0001532219 Name as filed on the most recent filing

Filed as Quinn Anthony G. (12)· Quinn Anthony (12)

49 transaction lines · from 24 filings · filed 2012-06-27 to 2025-01-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

49 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-01-13 P, Open-market purchase Generation Bio Co.GBIO 82,450, acquired Open Form 4 filing 0001415889-25-001417
2025-01-10 P, Open-market purchase Generation Bio Co.GBIO 120,759, acquired Open Form 4 filing 0001415889-25-001417
2023-12-01 P, Open-market purchase Generation Bio Co.GBIO 124,778, acquired Open Form 4 filing 0001415889-23-015857
2022-03-16 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 187,705, acquired Open Form 4 filing 0001209191-22-019929
2022-03-15 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 78,942, acquired Open Form 4 filing 0001209191-22-018942
2022-03-14 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 130,221, acquired Open Form 4 filing 0001209191-22-018942
2022-03-11 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 71,780, acquired Open Form 4 filing 0001209191-22-018942
2021-12-10 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 39,473, acquired Open Form 4 filing 0001209191-21-069350
2021-12-09 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 159,500, acquired Open Form 4 filing 0001209191-21-069350
2020-04-30 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 783,750, acquired Open Form 4 filing 0001209191-20-026662
2019-06-14 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 32,913, acquired Open Form 4 filing 0001567619-19-013411
2019-06-13 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 88,836, acquired Open Form 4 filing 0001567619-19-013411
2019-06-12 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 74,705, acquired Open Form 4 filing 0001567619-19-013411
2019-05-22 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 26,128, acquired Open Form 4 filing 0001567619-19-011852
2019-05-21 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 94,981, acquired Open Form 4 filing 0001567619-19-011852
2019-05-20 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 58,923, acquired Open Form 4 filing 0001567619-19-011852
2019-05-17 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 41,335, acquired Open Form 4 filing 0001567619-19-011561
2019-05-16 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 37,691, acquired Open Form 4 filing 0001567619-19-011561
2019-05-15 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 42,269, acquired Open Form 4 filing 0001567619-19-011561
2019-02-15 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 5,103, acquired Open Form 4 filing 0001567619-19-011561
2018-08-15 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 9,075, acquired Open Form 4 filing 0001567619-18-007640
2018-02-15 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 12,040, acquired Open Form 4 filing 0001567619-18-007640
2017-12-08 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 3,039, acquired Open Form 4 filing 0001140361-17-045528
2017-12-07 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 13,967, acquired Open Form 4 filing 0001140361-17-045528
2017-12-06 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 24,072, acquired Open Form 4 filing 0001140361-17-045528
2017-12-05 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 24,976, acquired Open Form 4 filing 0001140361-17-045127
2017-12-04 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 39,624, acquired Open Form 4 filing 0001140361-17-045127
2017-12-01 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 18,578, acquired Open Form 4 filing 0001140361-17-045127
2016-04-12 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 100,000, acquired Open Form 4 filing 0001140361-16-060931
2015-04-27 S, Open-market sale Synageva Biopharma CorpGEVA 1,100,000, disposed Open Form 4 filing 0001246360-15-001885
2015-04-21 S, Open-market sale Synageva Biopharma CorpGEVA 1,080,000, disposed Open Form 4 filing 0001246360-15-001833
2015-04-15 S, Open-market sale Synageva Biopharma CorpGEVA 1,050,000, disposed Open Form 4 filing 0001246360-15-001816
2015-04-06 S, Open-market sale Synageva Biopharma CorpGEVA 2,766,201, disposed Open Form 4 filing 0001246360-15-001755
2014-09-02 S, Open-market sale Synageva Biopharma CorpGEVA 4 lines 701,404, disposed Open Form 4 filing 0001246360-14-003716
2014-04-01 S, Open-market sale Synageva Biopharma CorpGEVA 4 lines 1,670,691, disposed Open Form 4 filing 0001246360-14-002041
2013-01-18 S, Open-market sale Synageva Biopharma CorpGEVA 473,106, disposed Open Form 4 filing 0001246360-13-000567
2013-01-17 S, Open-market sale Synageva Biopharma CorpGEVA 10,000, disposed Open Form 4 filing 0001246360-13-000516
2013-01-16 S, Open-market sale Synageva Biopharma CorpGEVA 268,025, disposed Open Form 4 filing 0001246360-13-000516
2012-07-27 S, Open-market sale Synageva Biopharma CorpGEVA 321,501, disposed Open Form 4 filing 0001246360-12-003224
2012-07-26 S, Open-market sale Synageva Biopharma CorpGEVA 55,000, disposed Open Form 4 filing 0001246360-12-003224
2012-07-20 S, Open-market sale Synageva Biopharma CorpGEVA 30,000, disposed Open Form 4 filing 0001246360-12-003162
2012-07-19 S, Open-market sale Synageva Biopharma CorpGEVA 95,000, disposed Open Form 4 filing 0001246360-12-003162
2012-06-25 S, Open-market sale Synageva Biopharma CorpGEVA 1,056,874, disposed Open Form 4 filing 0001246360-12-002852

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 29
  • Open-market sale 20
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Quinn Anthony G., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001532219

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.